Nuclera Appoints William J. Kullback as Non-Executive Director
- Appointment of leading financial executive supports continued commercial development
- Current CFO at Telesis Bio, former CFO of BioLegend Inc.
Cambridge, UK, 18 February 2025: Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, today announced the appointment of William J. Kullback to its Board of Directors as a Non-Executive Director (NED).